GSK.L : Summary for GLAXOSMITHKLINE PLC ORD 25P - Yahoo Finance

U.S. Markets closed

GlaxoSmithKline plc (GSK.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,467.00-1.50 (-0.10%)
At close: 12:13 PM EST
People also watch:
BP.LAZN.LRDSB.LVOD.LULVR.L
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1,468.50
Open1,462.00
Bid1,450.00 x 175400
Ask1,489.00 x 417900
Day's Range1,451.50 - 1,471.50
52 Week Range1,277.25 - 1,745.56
Volume6,542,323
Avg. Volume9,283,245
Market Cap71.1B
BetaN/A
PE Ratio (TTM)240.49
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • TheStreet.comyesterday

    How to Buy GlaxoSmithKline at a 15% Discount

    Investors seeking more returns can not only get some yield, but also healthy dividends from buying options on stocks. Those who are seeking additional opportunities can purchase GlaxoSmithKline (GSK),

  • GlaxoSmithKline PLC (ADR) (GSK) Wins Approval Of Its Asthma Drug Nucala
    Insider Monkeyyesterday

    GlaxoSmithKline PLC (ADR) (GSK) Wins Approval Of Its Asthma Drug Nucala

    The National Institute for Health and Care Excellence (NICE) has confirmed the approval of a new injectable asthma drug from GlaxoSmithKline PLC (ADR) (NYSE:GSK). Nucala, a first-in-class antibody treatment had earlier suffered a major setback of rejection, which had been occasioned by cost-effectiveness concerns. NICE had also claimed that the drug would be used in less […]

  • Investopediayesterday

    Glaxo and Innoviva Get Positive News (GSK, INVA)

    Glaxo and Innoviva are moving higher on the heels of positive news in both Europe and Japan for a COPD drug.